This page lists the SEC filings reported by SECTORAL ASSET MANAGEMENT INC.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | SECTORAL ASSET MANAGEMENT INC | eFFECTOR Therapeutics, Inc. | 2,382,644 | 3.7% | EDGAR |
SC 13G/A | 2024-02-14 | SECTORAL ASSET MANAGEMENT INC | Galera Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-13 | SECTORAL ASSET MANAGEMENT INC | eFFECTOR Therapeutics, Inc. | 2,382,644 | 5.7% | EDGAR |
SC 13G | 2023-02-13 | SECTORAL ASSET MANAGEMENT INC | Galera Therapeutics, Inc. | 1,666,666 | 5.8% | EDGAR |
SC 13G | 2022-02-11 | SECTORAL ASSET MANAGEMENT INC | eFFECTOR Therapeutics, Inc. | 2,382,744 | 5.9% | EDGAR |
SC 13G/A | 2021-02-12 | SECTORAL ASSET MANAGEMENT INC | Aprea Therapeutics, Inc. | 163,681 | 0.8% | EDGAR |
SC 13G/A | 2020-02-13 | SECTORAL ASSET MANAGEMENT INC | LA JOLLA PHARMACEUTICAL CO | - | 0.0% | EDGAR |
SC 13G | 2020-02-13 | SECTORAL ASSET MANAGEMENT INC | Aprea Therapeutics, Inc. | 1,470,339 | 7.0% | EDGAR |
SC 13G | 2019-02-13 | SECTORAL ASSET MANAGEMENT INC | LA JOLLA PHARMACEUTICAL CO | 1,759,171 | 6.7% | EDGAR |
SC 13G/A | 2018-02-13 | SECTORAL ASSET MANAGEMENT INC | COLLEGIUM PHARMACEUTICAL, INC | 1,426,862 | 4.4% | EDGAR |
SC 13G/A | 2017-02-10 | SECTORAL ASSET MANAGEMENT INC | Advaxis, Inc. | 690,074 | 1.7% | EDGAR |
SC 13G/A | 2017-02-10 | SECTORAL ASSET MANAGEMENT INC | AMICUS THERAPEUTICS INC | 5,100,198 | 3.6% | EDGAR |
SC 13G | 2017-02-10 | SECTORAL ASSET MANAGEMENT INC | COLLEGIUM PHARMACEUTICAL, INC | 2,104,756 | 7.4% | EDGAR |
SC 13G/A | 2016-02-12 | SECTORAL ASSET MANAGEMENT INC | AMICUS THERAPEUTICS INC | 7,973,436 | 6.7% | EDGAR |
SC 13G/A | 2016-02-12 | SECTORAL ASSET MANAGEMENT INC | OncoMed Pharmaceuticals Inc | - | - | EDGAR |
SC 13G | 2016-02-12 | SECTORAL ASSET MANAGEMENT INC | Advaxis, Inc. | 1,790,715 | 5.3% | EDGAR |
SC 13G/A | 2015-02-13 | SECTORAL ASSET MANAGEMENT INC | IRONWOOD PHARMACEUTICALS INC | - | - | EDGAR |
SC 13G | 2015-02-13 | SECTORAL ASSET MANAGEMENT INC | OncoMed Pharmaceuticals Inc | 1,598,293 | 5.4% | EDGAR |
SC 13G | 2015-02-13 | SECTORAL ASSET MANAGEMENT INC | AMICUS THERAPEUTICS INC | 4,765,498 | 5.1% | EDGAR |
SC 13G/A | 2014-02-12 | SECTORAL ASSET MANAGEMENT INC | SEQUENOM INC | - | 0.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.